Friday, 29 March 2024


WuXi STA signs exclusive technology and marketing partnership with BioLingus

19 February 2019 | News

The collaboration will help further integrate the advantages of WuXi STA drug product services and expedite the development of BioLingus' pipeline and usage of sublingual delivery technology

Image Source : gerhardhealer.com

Image Source : gerhardhealer.com

STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, and BioLingus, a Swiss biotech company, have formed an exclusive technology and marketing collaboration for sublingual delivery. 

Under the terms of the collaboration, WuXi STA will have exclusive access to BioLingus technology for sublingual and buccal delivery in the contract development and manufacturing organization (CDMO) sector. BioLingus has developed a novel platform - with patents secured in major countries around the world - to stabilize and deliver sublingually (orally under the tongue) drug targets including small molecules, peptides and proteins that are currently administered to patients via injection.

The collaboration will help further integrate the advantages of WuXi STA drug product services and expedite the development of BioLingus' pipeline and usage of sublingual delivery technology.

In 2017, WuXi STA merged with WuXi AppTec's Pharmaceutical Development Services unit, realizing a seamless integration of the entire chemistry, manufacturing and controls (CMC) supply chain. Over the past year, two new commercial drug product facilities - in Shanghai and Wuxi city, Jiangsu province - have come into operation, enabling WuXi STA to support solid dosage drug development from pre-clinical to commercial, with several phase III and commercial drug product projects underway. The newly introduced sublingual delivery technology will further deepen the scale of solid dosage drug capabilities in WuXi STA, providing customers with more flexible, diverse and advanced solutions.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account